Nolan-Stevauxet al. demonstrated that deletion of Smo receptor in pancreatic epithelium had no effect on KRAS induced tumor formation, nor on GLI1 expression in epithelial cells (Nolan-Stevauxet al., 2009). The gene discussed is GLI1; the disease is neoplasm.